Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

Stopped early

Conditions studied: Dupuytren's Contracture

In brief

This is an observational study, meaning participants will not receive any investigational treatment as part of this study. Researchers will collect real-world data (RWD), based on usual care, to gain a more in-depth knowledge of the natural history and the treatment outcomes of Dupuytren's Contracture (DC) to evaluate the management of DC.

Key facts

Study ID

NCT05877066

Run by

Endo USA Inc., a Keenova Therapeutics Company

People needed

130

Starts

2023-06-14

Expected to finish

2024-02-26

Last updated by the study team

2024-04-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Endo Pharmaceuticals Clinical Site 6 — Phoenix, Arizona, United States
• Endo Pharmaceuticals Clinical Site 5 — Greenwich, Connecticut, United States
• Endo Pharmaceuticals Clinical Site 4 — Temple Terrace, Florida, United States
• Endo Pharmaceuticals Clinical Site 2 — Indianapolis, Indiana, United States
• Endo Pharmaceuticals Clinical Site 1 — Eatontown, New Jersey, United States
• Endo Pharmaceuticals Clinical Site 7 — Charlotte, North Carolina, United States
• Endo Pharmaceuticals Clinical Site 3 — Bend, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.